Navigation Links
Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
Date:4/2/2009

BETHESDA, Md., April 2 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the filing of the first clinical trial application (CTA) in Europe by its partner Nycomed for the anti-GM-CSF antibody MT203. Micromet received a payment of 1.5 million Euro (US$ 2.0 million) from Nycomed for the achievement of this milestone.

Under a 2007 agreement between the two companies, Micromet and Nycomed are developing MT203, a human anti-GM-CSF antibody that may be useful for the treatment of various inflammatory and autoimmune diseases. Preclinical studies support development of MT203 for the treatment of rheumatoid arthritis and several other diseases, including multiple sclerosis, psoriasis, asthma and chronic obstructive pulmonary disease.

"Since the start of our collaboration with Nycomed in 2007, we have made excellent progress on the preclinical development of MT203," said Jens Hennecke, Micromet's Senior Vice President of Business Development. "The filing of the CTA represents an important milestone and we are looking forward to the start of clinical trials with MT203."

About Micromet

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, MD and Munich, Germany. The Company is focused on developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company's novel antibody technology is based on its proprietary BiTE(R) antibody platform, representing a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease related cells.
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., WESTBURY, N.Y., Nov. 6 Reposse...machine tools in the third quarter of 2009 decline...ing to Nassau Asset Management,s NasTrac Quarterly...y,s activity reports for both repossessions and or...sessions for both construction and printing equipm...
(Date:11/6/2009)..., CHARLESTON, S.C., Nov. 6 /PRNewswire-USNewsw...e stopping in South Carolina and Georgia throughou...rder to help uninsured and financially-struggling ...de prescription medicines for free or nearly free....0.2 percent, the Partnership for Prescription Assi...
(Date:11/6/2009)..., HOPKINTON, Mass., Nov. 6 Facet...red all of the assets of Archus Orthopedics. The a...on in product offerings, intellectual property and...ion. "This is a win for patients suffering from lu...sident & CEO, Geoff Pardo. "This consolidatio...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Facet Solutions Acquires Archus Orthopedics 2Dreyers Edys and Nestle Ice Cream Products NOT Involved in Cookie Dough Recall 49511 1Mayo researchers 3A Dramatic outcomes in prostate cancer study 49509 1Mayo researchers 3A Dramatic outcomes in prostate cancer study 49509 2Research explores interactions between nanomaterials biological systems 8932 1Research explores interactions between nanomaterials biological systems 8932 2Research explores interactions between nanomaterials biological systems 8932 3Research explores interactions between nanomaterials biological systems 8932 4
...U, Jan. 7 Hawaii Biotech, Inc. announced today,th...and Drug Administration,(FDA) that it may proceed ...uman volunteers with its recombinant, subunit West...ngle site in Hawaii, which the company currently,e...completion of financing,sufficient funding to comp...
...IK, Iceland, Jan. 6 deCODE scientists today,repor... the company has,linked to increased risk of heart... in risk of abdominal aortic aneurysm (AAA) and in... genetic variant ever found to,associate with eith...ce,variant on 9p21 associates with myocardial infa...
Other Medicine Technology:Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials 2Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease 2Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease 3
(Date:11/8/2009)...tical legislation would strengthen Medicare, impro.... 8 SUMMARY: Yesterda...d critical health care reform legislation that wou...ination by insurance companies that prices million... ,, The Affordable Health Care for America Act...
(Date:11/8/2009)...P Praises House Passage of Health Care Reform Bill...icare, improve coverage for all Americans ,, H...- ,, SUMMARY: Last night the United States H...e reform legislation that would strengthen Medicar...companies that prices millions of Americans out of...
(Date:11/8/2009)... UCW Academy of Health holds open h... Victoria, BC (Vocus) November 8, 2009 -- UCW Acad...reer in British Columbia’s health care indus...esday, November 25, 2009. , ,UCW Academy of Healt...ration, nursing and social services, designs its p...
(Date:11/8/2009)...er Costs and Crushing Taxes Nail Nation,s Job Crea...re/ -- In response to U.S. House passage of the he...ntrepreneurship Council (SBE Council) president &a...ent: ,, "Make no mistake, those voting for H.R...ith higher costs and crushing taxes and penalties....
(Date:11/8/2009)...INGTON, Nov. 7 Tonight ... Health Care for America Act, landmark health refo... access to quality, affordable, stable and secure ...s down on some of the insurance industry,s worst p...icans and cut the deficit by $104 billion over ten...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3
...According to the researchers at the University of ...ial for the expression of the neural stem cell gen... stem cells are totipotent cells and can different...e adult eye. Led by Dr. Larysa H. Pevny, an assist...
...It has been found that about 44% of women are vict...y affected their physical and mental health. // Sc...e unclear. The Group Health Cooperative in Seattle...ith colleagues from Harborview Injury Prevention a...
...A study has found that both lesbians and heterosex...tain body odors. // According to a previous study ...es in brain process of odor in both heterosexual a...ir existence in humans is questionable. Researcher...
...Professor Simon Wessely, of the King's Center for ...said that British soldiers returning from Iraq are...archer and his team are examining whether there ha...ent to Iraq and those who had not. In the end they...
...A study published in the British Journal of Clinic... and unwanted pregnancies could be prevented by pr...s they have the advantage of easy access. UK re...family planning clinics and community pharmacies. ...
...Recent research has revealed that several parents ...on their children's develoopment//. Their findi...Sports Medicine. The findings are informed by ...ing. The coaches had all spent an average of 17 ye...
Other Medicine News:Health News:Importance of Gene in Eye Development 2Health News:Research into Intimate Partner Violence 2Health News:Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies 2Health News:Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies 3Health News:Parents of Junior Athletes do More Harm than Good 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: